8-K: NorthView Acquisition Corp. Faces Nasdaq Delisting After Missing Business Combination Deadline

NorthView Acquisition Corporation will be delisted from the Nasdaq after failing to complete a business combination within the required timeframe, but plans to move to the OTC market and continue with its merger plans.

Summary

• NorthView Acquisition Corporation received a notice from Nasdaq stating that its securities will be delisted due to the company's failure to complete a business combination within 36 months of its IPO.
• Trading of NorthView's common stock, rights, and warrants will be suspended on Nasdaq starting December 27, 2024.
• Nasdaq will file a Form 25-NSE with the SEC to officially remove the company's securities from the exchange.
• NorthView intends to apply for listing on the OTC market under the same ticker symbols after delisting from Nasdaq.
• The delisting does not impact the company's planned business combination with Profusa Inc., which they are still pursuing.
• The merged entity plans to apply for listing on the Nasdaq after the business combination is complete.
• NorthView will remain a reporting entity under the Securities Exchange Act of 1934.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting from Nasdaq, which is a significant setback. However, the company's continued pursuit of the merger and plans to relist provide a glimmer of hope.

Positives

• The company is actively pursuing a listing on the OTC market to maintain trading of its securities.
• The planned business combination with Profusa Inc. is still in progress.
• The company intends to relist on Nasdaq after the merger with Profusa Inc.

Negatives

• The company failed to meet the Nasdaq deadline for completing a business combination.
• The company's securities will be delisted from Nasdaq, a major exchange.
• There is no guarantee that the company's securities will be admitted to trading on the OTCQB Market.
• There is no guarantee that a broker will continue to make a market in the company's securities on the OTC market.

Risks

• The company faces the risk of not being able to list on the OTCQB market and may have to trade on the Pink Market.
• There is a risk that the business combination with Profusa Inc. may not be successful.
• There is no guarantee that the company's securities will ultimately be listed on Nasdaq after the merger.
• The delisting from Nasdaq could negatively impact investor confidence and the company's ability to raise capital.

Future Outlook

The company intends to apply for listing on the OTC market and pursue its business combination with Profusa Inc., with the goal of relisting on Nasdaq after the merger.

Management Comments

• The company will not appeal Nasdaq's determination to delist the company's securities.
• The company intends to apply for the listing of its securities on the OTC market under the same ticker symbols after they are delisted from Nasdaq.
• The delisting from Nasdaq does not affect the company's previously announced business combination with Profusa Inc., as both parties continue to work to effectuate the closing of the business combination.

Industry Context

This announcement is typical for SPACs that fail to complete a business combination within the required timeframe. It highlights the risks associated with SPAC investments and the importance of timely deal execution.

Comparison to Industry Standards

• Many SPACs face similar delisting risks if they fail to complete a merger within the stipulated timeframe, typically 24-36 months.
• The move to the OTC market is a common step for companies delisted from major exchanges, but it often results in lower trading volumes and liquidity.
• The company's plan to relist on Nasdaq after the merger is a standard approach for SPACs that successfully complete a business combination.

Stakeholder Impact

• Shareholders will experience a loss of value due to the delisting from Nasdaq.
• Shareholders may face reduced liquidity as the company moves to the OTC market.
• Employees may experience uncertainty due to the company's delisting and merger process.
• Creditors may be concerned about the company's financial stability due to the delisting.

Next Steps

• The company will apply for listing on the OTC market.
• The company will continue to work towards completing the business combination with Profusa Inc.
• The merged entity will apply for listing on the Nasdaq Stock Market.

Key Dates

Keywords

Delisting, Nasdaq, Business Combination, SPAC, OTC Market, Merger, Profusa Inc., NVAC, Securities, Listing